Abstract
Objective
Kawasaki disease (KD) is an acute form of febrile vasculitis that occurs in early childhood. The multisystemic vasculitis common in patients with KD may influence blood perfusion in the brain, and thus caregivers of children with KD may feel stress with regard to caring for them. Intravenous immunoglobulin (IVIG) infusion is the standard treatment for acute KD, and the most serious complication of KD is coronary artery aneurysms (coronary artery lesion (CAL)). This study aimed to investigate the relationships between KD heterogeneity and the risk of patients’ cognitive impairment or caregivers’ parenting stress.
Design
A case–control study with consecutive sampling.
Setting
A medical centre (Kaohsiung Chang Gung Memorial Hospital, Taiwan).
Participants
This study consisted of 176 patients with KD (mean age: 5.5 years, 60.8% boys) and 85 healthy children (mean age: 6.4 years, 54.1% boys).
Primary and secondary outcome measures
Based on the children’s age, each patient with KD and control subject was administered an assessment using the Mullen Scales of Early Learning or the Wechsler Intelligence Scale, and parenting function of their caregivers was assessed using the Parenting Stress Index (PSI)-Short Form.
Results
We observed no significant differences in any developmental index, cognitive function or parenting stress between patients with KD and controls. Among the children with KD, IVIG administration nor CAL was associated with children’s cognitive scores. However, the caregivers of patients who had CAL suffered from greater PSI total scores than those of patients without CAL. Furthermore, the caregivers who had education levels of a master’s degree or above showed less parenting stress than those who had an education level of college or lower.
Conclusion
Caregivers’ education is associated to parenting stress, and caregivers of patients with KD who developed CAL may feel stress about the unpredictable sequela caused by CAL for their children. Such caregivers may require support to fulfil their parenting roles.
Keywords: immunology, paediatric cardiology, developmental neurology & neurodisability, community child health
Strengths and limitations of this study.
We carried out a comprehensive study about cognitive impairment of patients with Kawasaki disease (KD) or parenting stress of caregivers.
This is the first study indicating that caregivers of patients with KD who developed coronary artery aneurysms may feel stress about the unpredictable sequela.
Owing to small case numbers, it is difficult to make a strong conclusion about cognitive impairment.
We used a case–control design; therefore, no causal relationships could be identified.
Introduction
Kawasaki disease (KD) manifests with acute fever, mainly affects children aged <5 years, and involves multisystemic vasculitis of unknown aetiology.1 2 Although it occurs around the world, KD incidence rates are especially high in East Asia, particularly Japan, Korea and Taiwan.3 4 The primary clinical characteristics of KD consist of prolonged fever, diffuse mucosal inflammation, bilateral non-purulent conjunctivitis, non-suppurative cervical lymphadenopathy, indurative angioedema of the hands and feet and polymorphous skin rashes.5–7 Intravenous immunoglobulin (IVIG) infusion has been established as the standard treatment for acute KD,8 but 10%–20% of patients still show resistance to IVIG therapy and are at high risk for coronary artery complications,9 of which, the formation of coronary artery lesions (CALs) is the most serious.10 These studies suggest that 20%–24% of children with KD, even when treated with IVIG, still suffer from CAL and 4% with coronary artery aneurysm formation.11 12
In addition to the harm caused to the coronary arteries, KD is also characterised by multisystemic vasculitis and may thus affect blood perfusion and cause inflammatory changes in the brain.13 14 Central nervous system symptoms, such as lethargy, cranial nerve palsy and prolonged partial seizures, occur in 1%–30% of patients with KD.15–18 Fortunately, these studies have consistently demonstrated that patients with KD are not associated with cognitive impairment sequelae.19–21 However, different responses to IVIG treatment and the development of coronary aneurysms may be related to a discrepancy in patients’ immunological profiles or genetic background.22 Therefore, the relationships between heterogeneity of KD and the risk of cognitive impairments warrant further investigation.
Our study revealed that children with KD suffered acute and prominent impairment in health-related quality of life, and the impairments even exceeded that of children newly diagnosed with cancer.23 Furthermore, patients with KD, as well as their caregivers, may consistently worry about patients’ potential risk of cardiac event-related death.24 With a lack of support and adequate knowledge available at the societal level, patients’ caregivers may experience stress from coping with their children’s needs and fulfilling their parenting roles. Owing to the uncertainty of the long-term KD prognosis, the parents of children with coronary artery complications suffered from persistent anxiety even years after the acute phase of the illness.25 The psychosocial burden of parents is associated with intensity of medical experience and family’s psychosocial limitations.26 However, the evidence with regarding to parenting stress among caregivers of children with KD is still scarce. Therefore, recruiting a control group is helpful to compare the cognitive profiles and parenting stress between children with KD and those without KD.27
To fill this research gap, we performed a clinical survey to explore the potential factors (eg, responses to IVIG treatment or comorbid CAL) associated with cognitive profiles in patients with KD. In addition, we investigated whether the caregivers of children with KD and healthy controls exhibited different parenting stress, and to examine the factors correlated to caregivers’ parenting stress among children with KD.
Methods
Participants
We recruited a total of 176 patients with KD from the Department of Pediatrics from June 2016 to July 2018, Kaohsiung Chang Gung Memorial Hospital, Taiwan or communities near the hospital. A senior clinician diagnosed patients with KD in accordance with the recommended universal KD criteria published by the American Heart Association.28 The diagnostic criteria of KD includes fever that lasts longer than 5 days, as well as four of the following five symptoms: diffuse mucosal inflammation with strawberry tongue and fissure lips, bilateral non-purulent conjunctivitis, indurative angioedema of the hands and feet, dysmorphic skin rashes and unilateral cervical lymphadenopathy, as stated in our previous reports.29 Once their symptoms were remitted, patients with KD were administered a developmental or cognitive assessment in either outpatient department or in the ward.
Because most of our patients with KD were recruited from the outpatient department, we recruited 85 healthy children from communities around Kaohsiung Chang Gung Memorial Hospital or children suffering from upper respiratory tract infection whose symptoms were currently in remission as a control group. We excluded any patients with other immunological diseases (asthma, allergic rhinitis, atopic dermatitis or allergic conjunctivitis) or major physical illnesses (such as genetic, metabolic or infectious conditions).
CAL assessment
All participants were provided with a structured questionnaire to collect demographic data, such as age, gender and age of onset. We recorded body temperature every 6 hours during the febrile stage. The CAL was defined as a luminal diameter of >3 mm in a child aged <5 years or >4 mm in those aged ≥5 years, when the internal diameter of a segment is 1.5 times or greater than that of an adjacent segment, or when the luminal contour is clearly irregular or has a Z score >2.5 SD.30 31 We estimated the Z score of the proximal right coronary artery, left main coronary artery and proximal left anterior descending artery, as well as the maximum Z score of coronary arteries both at baseline and 6–8 weeks with 2D echocardiography. The body weight and height used to calculate Z scores were obtained from the Taiwan Society of Pediatric Cardiology website (http://www.tspc.org.tw/service/z_score.asp). The IVIG resistance was defined as persistent or recrudescent fever for at least 36 hours after the end of their IVIG infusion but not >7 days.32
Neurocognitive assessments
Each patient with KD and control subject were administered a developmental or cognitive assessment performed by an experienced child psychologist in a room designed to reduce testing condition variables. Patients aged <4 years were assessed using the Mullen Scales of Early Learning (MSEL); patients between the ages of 4 and 7 years were examined using the Wechsler Preschool and Primary Scale of Intelligence-Fourth Edition (WPPSI-IV) and patients aged >7 years were tested using the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV).
The MSEL, a standardised developmental assessment for newborns through children of age 68 months, offers an overall index of cognitive ability and developmental delay.33 It consists of five subscales: Gross Motor (only for children aged <33 months), Visual Reception, Fine Motor, Expressive Language and Receptive Language. After scoring each item, the crude scores of each of the five scales are transformed into normalised age-specific scores, referred to as T scores. The T scores of all except the Gross Motor Scale are added together and converted into the Early Learning Composite (ELC) score. The MSEL has been applied in Taiwan’s toddler samples.21 34
The WPPSI-IV is an individually administered, standardised tool for evaluating intelligence in children between the ages of 2 years 6 months and 7 years 7 months.35 The test takes about 30–45 min for children between the ages of 2 years 6 months and 3 years 11 months and provides a Full-Scale Intelligence Quotient (FSIQ), Verbal Comprehension Index (VCI), Visual Spatial Index (VSI) and Working Memory Index (WMI). For children between the ages of 4 years and 7 years 7 months, it takes about 45–60 min and provides a FSIQ, VCI, VSI, Fluid Reasoning Index, WMI and Processing Speed Index (PSI).36 The WPPSI-IV has been used in clinical study in Taiwan.21 37
The WISC-IV is an individually administered and norm-referenced tool developed to measure the intelligence of children aged from 6 to 16 years.38 The WISC-IV includes 10 core and 5 supplemental subtests. The core subtests create four factor indexes, including the VCI, the Perceptual Reasoning Index, the WMI and the PSI. Meanwhile, the 10 core subtests form the FSIQ. Each factor index, as well as the FSIQ, has a population mean of 100 and an SD of 15. The WISC-IV has been applied for Taiwanese school-aged children in several clinical studies.39 40
Parenting stress
Caregivers’ characteristics, including age, gender and education levels, were recorded, and their parenting function was assessed using the Parenting Stress Index-Short Form (PSI-SF). The PSI-SF, a widely adopted self-administered questionnaire for evaluating parenting stress, includes 36 items (rated on a 5-point Likert scale) and stems directly from the full-length 120-item Parenting Stress Index test.41 The PSI-SF provides scores in the following subscales: (a) Parental Distress, (b) Parent–Child Dysfunctional Interaction and (c) Difficult Child. The three subscores are added together to yield a total parenting stress score.42 Studies have reported that the Chinese version of the PSI-SF is a reliable assessment tool for identifying parenting stress with a need for intervention in clinical practices.43–45
Statistical analysis
All data processing and statistical analyses were performed using the SPSS software, V.14.0. Two-tailed p values <0.05 were considered statistically significant.
The sample size calculation was estimated using the G*Power software. Based on the settings of 80% power, p=0.05, effect size=0.4 and allocation ratio N1/N2=2, the sample size should be 149 in group 1 and 75 in group 2. The common assumptions made when performing a t test include those regarding the scale of measurement, random sampling, normality of data distribution, adequacy of sample size and equality of variance in SD. The assumptions of the χ2 include the data in the cells should be frequencies or counts of cases rather than percentages or some other transformation of the data. The levels (or categories) of the variables are mutually exclusive. Multiple linear regression analysis makes several key assumptions as following: linear relationship, multivariate normality, no or little multicollinearity, no auto-correlation and homoscedasticity.46 The literature with regarding to cognitive function and parenting stress among children with KD is still scarce; therefore, the covariates selected for the multiple linear regression model were based on the variables collected in clinical settings.
We used the χ2 test to compare differences in categorical variables between patients with KD and those without KD. An independent t-test was adopted to compare continuous variables between the two groups. We performed a general linear model to observe the difference in children’s cognition and caregivers’ stress between patients with KD and controls, controlled for children’s age and caregivers’ education levels. The cognitive scores of patients who were assessed using the MSEL were set as the ELC scores, and the cognitive scores of those assessed with the WPPSI or WISC-IV were set as the FSIQ. The independent variables were the characteristics of the children and caregivers. Furthermore, multiple linear regression was adopted to determine the factors associated with parental stress among the patients with KD. The dependent variable was set as the total PSI score, and the independent variables were the characteristics of the children and caregivers.
Results
The study participants consisted of 176 patients with KD (mean age: 5.5 years, 60.8% boys) and 85 healthy children (mean age: 6.4 years, 54.1% boys; table 1). The healthy children were older than patients with KD (p=0.035), and the caregivers in the control group had higher education levels than those in the KD group (p=0.018). Apart from this, no significant differences in gender or caregivers’ characteristics between children with KD and controls. No significant differences in development scores measured using the MSEL or cognitive scores measured using the WPPSI or WISC-IV were observed between the children with KD and the healthy controls. When comparing the caregivers of patients with KD to those of the controls, none of the PSI subscales showed a significant difference.
Table 1.
Characteristics of children with KD and healthy controls
| KD (n=176) | Controls (n=85) | Statistic† | P value | |
| Children’s characteristics | ||||
| Age (months) | 66.5±39.0 | 77.3±38.0 | −2.114 | 0.035* |
| Age of KD onset (months) | 21.6±17.7 | – | N/A | N/A |
| Sex | 1.054 | 0.305 | ||
| Male | 107 (60.8) | 46 (54.1) | ||
| Female | 69 (39.2) | 39 (45.9) | ||
| Intravenous immunoglobulin | N/A | N/A | ||
| None | 7 (4.0) | – | ||
| Once | 156 (88.6) | – | ||
| Twice | 13 (7.4) | – | ||
| Coronary artery aneurysms | N/A | N/A | ||
| With | 74 (42.0) | – | ||
| Without | 102 (58.0) | – | ||
| Mullen Scales of Early Learning | ||||
| Gross Motor‡ | 52.0±13.1 | 52.7±12.0 | 0.091 | 0.765 |
| Visual Reception | 54.0±13.8 | 53.1±17.2 | 0.062 | 0.804 |
| Fine Motor | 50.2±13.4 | 50.1±11.6 | 0.037 | 0.847 |
| Receptive Language | 57.0±11.5 | 51.2±10.7 | 3.838 | 0.054 |
| Expressive Language | 51.7±13.2 | 50.5±11.2 | 0.229 | 0.634 |
| Composite scores | 106.2±19.4 | 105.0±19.2 | 0.087 | 0.768 |
| WPPSI | ||||
| Full Scale IQ | 103.7±10.4 | 107.6±11.7 | 1.380 | 0.243 |
| Verbal Comprehension Index | 105.2±10.7 | 107.1±14.3 | 1.132 | 0.290 |
| Visual Spatial Index | 98.8±14.9 | 101.5±10.9 | 0.262 | 0.610 |
| Fluid Reasoning Index | 107.0±12.0 | 107.0±13.9 | 0.003 | 0.960 |
| Working Memory Index | 99.0±12.4 | 100.3±15.3 | 0.150 | 0.700 |
| Processing Speed Index | 103.3±12.5 | 106.9±12.7 | 0.683 | 0.411 |
| WISC-IV | ||||
| Full Scale IQ | 109.1±11.1 | 109.7±17.4 | 1.039 | 0.311 |
| Verbal Comprehension Index | 108.2±13.4 | 111.3±16.3 | 0.022 | 0.882 |
| Perceptual Reasoning Index | 106.1±14.8 | 106.4±17.2 | 0.576 | 0.450 |
| Working Memory Index | 110.3±13.1 | 111.4±15.3 | 0.331 | 0.567 |
| Processing Speed Index | 103.0±14.3 | 98.4±15.1 | 3.928 | 0.051 |
| Caregivers’ characteristics | ||||
| Age (years) | 37.6±4.8 | 38.2±5.0 | −0.889 | 0.375 |
| Sex | 1.096 | 0.295 | ||
| Male | 26 (14.9) | 17 (20.0) | ||
| Female | 149 (85.1) | 68 (80.0) | ||
| Education levels | 8.080 | 0.018* | ||
| High school or lower | 81 (46.8) | 29 (34.1) | ||
| College | 77 (44.5) | 39 (45.9) | ||
| Master or above | 15 (8.7) | 17 (20.0) | ||
| Family expenditure (per month)§ | 0.515 | 0.773 | ||
| <50 000 NT$ | 94 (59.9) | 42 (55.3) | ||
| 50 000–100 000 NT$ | 46 (29.3) | 24 (31.6) | ||
| >100 000 NT$ | 17 (10.8) | 10 (13.2) | ||
| PSI-SF | ||||
| Defensive Responding | 18.0±5.2 | 18.0±5.3 | 0.193 | 0.660 |
| Parental Distress | 30.2±8.2 | 30.0±9.0 | 0.003 | 0.958 |
| Parent–Child Dysfunctional Interaction | 23.1±7.0 | 24.4±8.3 | 2.204 | 0.139 |
| Difficult Child | 27.4±8.1 | 29.0±8.6 | 3.836 | 0.051 |
| Total score | 80.7±20.4 | 83.1±21.9 | 1.749 | 0.187 |
Data are expressed as mean±SD or n (%).
*p<0.05.
†Statistical values are expressed as t value or χ2.
‡Gross Motor is only for children aged <33 months.
§NT$ represents new Taiwan dollars (US$1=31.1 NT$). There were 28 missing values (19 patients with ADHD and 9 controls).
ADHD, attention deficit hyperactivity disorder; KD, Kawasaki disease; PSI-SF, Parenting Stress Index-Short Form; WISC-IV, Wechsler Intelligence Scale for Children-Fourth Edition; WPPSI, Wechsler Preschool and Primary Scale of Intelligence.
Of the children with KD, the mean age of KD onset was 21.6 months; 4% of them never received IVIG treatment, and 88.6% and 7.4% received IVIG treatment once and twice, respectively; 58% of them had no CAL and 42% of them had CAL. Table 2 shows the relationship between children’s and caregivers’ characteristics and the cognitive score among children with KD. We found that neither IVIG administration nor CAL was associated with the cognitive score of children with KD. The characteristics of children and caregivers were also not correlated with cognitive score.
Table 2.
Characteristics of children with KD and their caregivers regarding cognition development of children with KD
| B (95% CI) | P value | |
| Children’s characteristics | ||
| Age (months) | 0.07 (−0.01 to 0.15) | 0.067 |
| Age of KD onset (months) | −0.01 (−0.16 to 0.13) | 0.846 |
| Sex | ||
| Male | 1.38 (−3.43 to 6.19) | 0.572 |
| Female | 1 | |
| Intravenous immunoglobulin | ||
| None | 3.01 (−10.86 to 16.88) | 0.669 |
| Once | 1.43 (−7.25 to 10.11) | 0.746 |
| Twice | 1 | |
| Coronary artery aneurysms | ||
| Without | 1.32 (−3.42 to 6.07) | 0.583 |
| With | 1 | |
| Caregivers’ characteristics | ||
| Age (years) | −0.07 (−0.66 to 0.52) | 0.824 |
| Sex | ||
| Male | −5.23 (−11.97 to 1.52) | 0.128 |
| Female | 1 | |
| Education levels | ||
| High school or lower | −3.73 (−12.25 to 4.78) | 0.388 |
| College | −1.13 (−9.60 to 7.35) | 0.794 |
| Master or above | 1 | |
The dependent variable in the multiple linear regression model is a cognitive score (Early Learning Composite Score of the MSEL or the Full-Scale IQ of the WPPSI or WISC-IV). Data are expressed as B value, 95% CI and p value using multiple linear regression model. Adjusted R2 of this regression model=0.054.
KD, Kawasaki disease; MSEL, Mullen Scales of Early Learning; WISC-IV, Wechsler Intelligence Scale for Children-Fourth Edition; WPPSI, Wechsler Preschool and Primary Scale of Intelligence.
Regarding the factors related to the total scores of PSI (table 3), caregivers of patients wth KD who had CAL suffered from greater parenting stress than the caregivers of patients without CAL (p=0.019). Furthermore, the caregivers who had education levels of a master’s degree or above showed less parenting stress than those who had an education level of college (p=0.010) or lower (p=0.021).
Table 3.
Characteristics of children with KD and their caregivers regarding parenting stress of the children’s caregivers
| B (95% CI) | P value | |
| Children’s characteristics | ||
| Age (months) | 0.01 (–0.09 to 0.11) | 0.834 |
| Age of KD onset (months) | −0.18 (–0.37 to 0.01) | 0.066 |
| Sex | ||
| Male | 0.37 (–5.89 to 6.63) | 0.907 |
| Female | 1 | |
| Intravenous immunoglobulin | ||
| None | 1.46 (-16.60 to 19.51) | 0.874 |
| Once | −5.92 (-17.22 to 5.39) | 0.303 |
| Twice | 1 | |
| Coronary artery aneurysms | ||
| Without | −7.41 (–13.59 to 1.23) | 0.019* |
| With | 1 | |
| Caregivers’ characteristics | ||
| Age (years) | −0.11 (–0.88 to 0.66) | 0.784 |
| Sex | ||
| Male | −0.57 (–9.35 to 8.21) | 0.898 |
| Female | 1 | |
| Education levels | ||
| High school or lower | 13.11 (2.03 to 24.20) | 0.021* |
| College | 14.55 (3.52 to 25.58) | 0.010* |
| Master or above | 1 | |
The dependent variable in the multiple linear regression model is the total score of the Parenting Stress Index. Data are expressed as B value, 95% CI and p value using multiple linear regression model.
*p<0.05. Adjusted R2 of this regression model=0.072.
KD, Kawasaki disease.
Discussion
This study demonstrates the potential effect of KD heterogeneity on cognitive development and parenting stress. Our data revealed that no significant differences in developmental index, cognitive function or parenting stress between patients with KD and controls. Both IVIG administration and CAL development were not associated with cognitive profiles of children with KD. In addition, the profiles of parenting stress in caregivers of patients with KD were examined in this study. We found that caregivers’ education is associated to parenting stress, and the caregivers of patients who had CAL suffered from greater parenting stress than those of patients without CAL.
In our study sample, 4% never received IVIG, and 88.6% and 7.4% received IVIG treatment, once and twice, respectively. Although IVIG has been established as a standard treatment for KD,8 4% of patients still never received such intervention and 7.4% received IVIG treatment twice due to treatment resistance at the first administration. As the study sample included patients referred from local hospitals of remote areas, some of the patients may have missed the opportunity to be correctly diagnosed and receive IVIG at the critical period. Notably, 10%–20% of patients show resistance to IVIG therapy and are at risk for complications.9 Our study population with KD consisted of 42% patients who exhibited CAL, a higher proportion of CAL than has been reported in this literature.10 These studies suggest that approximately 20% of patients with KD suffer from CAL.47 This discrepancy may be due to Kaohsiung Chang Gung Memorial Hospital being the main medical centre in Southern Taiwan and patients recruited for this study possibly having a higher severity or greater comorbidities than those in general hospitals.
The results of this study show that KD is not related to cognitive impairment sequelae, which was generally consistent with the previous literature.19–21 Because IVIG reduces vasculitis that presumably underlies any cognitive impairment, we assumed that patients with KD who had a poor response to IVIG or had developed CAL may be related to a higher severity of systemic vasculitis.13 14 However, we found that neither IVIG administration nor CAL development was associated with cognitive performance. In our study population, most patients with KD (96%) received IVIG treatment. The case numbers of children who did not receive IVIG (only 4%) and treatment resistance (7.4%) were too small and it is difficult to make a sufficient comparison. Therefore, a future study with larger sample size is required to verify whether IVIG administration is associated with cognitive outcomes or not. Notably, a nationwide survey in Taiwan previously demonstrated that epilepsy and developmental delay were factors associated with cognitive impairments.21 Whether physical comorbidities other than KD have a greater influence on cognitive function than KD itself or the disease characteristics of KD warrants further research.
We provide more scientific evidence related to parental stress or mental health of caregivers of patients with KD and keeping in mind that situation implies more health service. It is noteworthy that patients’ caregivers were not assessed during patients’ acute phase of KD. The clinical meaning of our findings is that parenting stress of caregivers in children with KD during follow-up was comparable those of control children. Nevertheless, our data revealed that caregivers of patients who had CAL suffered from greater parenting stress than the caregivers of patients who did not have CAL. A previous study from Canada revealed a similar finding with our study. The parents of children with coronary artery complications may have suffered from a greater anxiety level.25 The psychological distress is associated with family characteristics, such as family income and maternal education.26 Children with persistent CAL may develop complications,11 so caregivers may worry, feel stressed and experience helplessness with regard to facing the uncertainty of their children’s risk of myocardial infarction and the possibility of sudden death. This finding suggests that the parental stress or mental health of caregivers of patients with CAL require particular assistance. Furthermore, caregivers with an education level of a master’s degree or above showed lower parenting stress than those who had education levels of college or lower. This finding may imply that caregivers with high education levels had greater internal or external resources to handle the patients’ physical illness.26 Alternatively, caregivers with lower education levels may require support or help to fulfil their parenting roles.
This study has certain limitations. First, owing to small case numbers of patients with KD without IVIG or treatment resistance, it is difficult to make a strong conclusion about cognitive impairment. Second, this is a case–control study, with a mean interval between KD onset and assessment for cognition and parenting stress of 40.5 months (ranged from 1 to 159 months). Therefore, the measurement for parenting stress was highly dependent on parental recall. The parenting stress reported herein did not necessarily represent the state of patients’ caregivers who take care of patients during the acute onset of KD. Third, CAL was only recorded as a categorical variable (with or without), but the influence of CAL severity on cognition or parenting stress was not assessed in this study. Moreover, we did not record physical comorbidities besides KD. Whether other comorbidities (ie, developmental delay or epilepsy) actually influence or moderate children’s cognitive development warrants further investigation. Moreover, an increase incidence of KD has been observed during the SARS-CoV-2 pandemic.48 It suggests that SARS-CoV-2 may trigger a severe hyperinflammatory syndrome, such as paediatric inflammatory multisystem syndrome or KD-like symptoms, in childhood.49 The influence of SARS-CoV-2 pandemic on the cognitive profiles of patients with KD and parenting stress of their caregivers warrants further investigation. Fourth, the KD group and control group were not perfectly matched in age and caregivers’ characteristics, and those differences may have influenced the results of this study. Finally, all participants were recruited from a single site, whether this finding can be generalised into other patient populations warrants further investigation.
Conclusion
No significant differences in developmental index, cognitive function or parenting stress between patients with KD and controls. In patients with KD, neither IVIG treatment nor CAL was associated with the cognitive profiles of patients with KD. This result is good news for caregivers and patients with KD, reassuring them that their IVIG response or CAL development will have no effect on their development milestones or cognitive function. However, caregivers of patients with KD who had CAL may feel stress about unpredictable sequela caused by CAL for their children. These caregivers may require support or help to fulfil their parenting roles.
Supplementary Material
Acknowledgments
The authors thank all participants in this study.
Footnotes
Contributors: L-JW and L-SC: conceptualised and designed the study and drafted the initial manuscript. Z-YT: recruited and assessed the patients. H-CK: designed the study, recruited the patients and approved the final manuscript to be submitted.
Funding: This study was supported by a grant from Kaohsiung Chang Gung Memorial Hospital, Taiwan (CMRPG8C1082, CMRPG8E1613, CORPG8F0013, CMRPG8J0611 and CMRPG8D0521).
Competing interests: None declared.
Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Provenance and peer review: Not commissioned; externally peer reviewed.
Data availability statement
Data are available upon reasonable request.
Ethics statements
Patient consent for publication
Not required.
Ethics approval
Chang Gung Memorial Hospital’s Internal Review Board approved this study (IRB No. 104-8261C), and we obtained the written informed consent from the parents or guardians of all participating children.
References
- 1. Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol 2016;67:1738–49. 10.1016/j.jacc.2015.12.073 [DOI] [PubMed] [Google Scholar]
- 2. Hara T, Nakashima Y, Sakai Y, et al. Kawasaki disease: a matter of innate immunity. Clin Exp Immunol 2016;186:134–43. 10.1111/cei.12832 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Singh S, Vignesh P, Burgner D. The epidemiology of Kawasaki disease: a global update. Arch Dis Child 2015;100:1084–8. 10.1136/archdischild-2014-307536 [DOI] [PubMed] [Google Scholar]
- 4. Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 2012;22:79–85. 10.2188/jea.JE20110131 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Zhu FH, Ang JY. The clinical diagnosis and management of Kawasaki disease: a review and update. Curr Infect Dis Rep 2016;18:32. 10.1007/s11908-016-0538-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Rowley AH. The complexities of the diagnosis and management of Kawasaki disease. Infect Dis Clin North Am 2015;29:525–37. 10.1016/j.idc.2015.05.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Kuo H-C, Yang KD, Chang W-C, et al. Kawasaki disease: an update on diagnosis and treatment. Pediatr Neonatol 2012;53:4–11. 10.1016/j.pedneo.2011.11.003 [DOI] [PubMed] [Google Scholar]
- 8. Eleftheriou D, Levin M, Shingadia D, et al. Management of Kawasaki disease. Arch Dis Child 2014;99:74–83. 10.1136/archdischild-2012-302841 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Qiu H, He Y, Rong X, et al. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status. Postgrad Med 2018;130:442–7. 10.1080/00325481.2018.1468712 [DOI] [PubMed] [Google Scholar]
- 10. Chen KYH, Curtis N, Dahdah N, et al. Kawasaki disease and cardiovascular risk: a comprehensive review of subclinical vascular changes in the longer term. Acta Paediatr 2016;105:752–61. 10.1111/apa.13367 [DOI] [PubMed] [Google Scholar]
- 11. Joshi M, Tulloh R. Kawasaki disease and coronary artery aneurysms: from childhood to adulthood. Future Cardiol 2017;13:491–501. 10.2217/fca-2017-0039 [DOI] [PubMed] [Google Scholar]
- 12. Kuo H-C. Preventing coronary artery lesions in Kawasaki disease. Biomed J 2017;40:141–6. 10.1016/j.bj.2017.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Gitiaux C, Kossorotoff M, Bergounioux J, et al. Cerebral vasculitis in severe Kawasaki disease: early detection by magnetic resonance imaging and good outcome after intensive treatment. Dev Med Child Neurol 2012;54:1160–3. 10.1111/dmcn.12002 [DOI] [PubMed] [Google Scholar]
- 14. Korematsu S, Uchiyama S-ichi, Miyahara H, et al. The characterization of cerebrospinal fluid and serum cytokines in patients with Kawasaki disease. Pediatr Infect Dis J 2007;26:750–3. 10.1097/INF.0b013e3180f61708 [DOI] [PubMed] [Google Scholar]
- 15. Hikita T, Kaminaga T, Wakita S, et al. Regional cerebral blood flow abnormalities in patients with Kawasaki disease. Clin Nucl Med 2011;36:643–9. 10.1097/RLU.0b013e318217adfc [DOI] [PubMed] [Google Scholar]
- 16. Emiroglu M, Alkan G, Kartal A, et al. Abducens nerve palsy in a girl with incomplete Kawasaki disease. Rheumatol Int 2016;36:1181–3. 10.1007/s00296-016-3515-2 [DOI] [PubMed] [Google Scholar]
- 17. Bailie NM, Hensey OJ, Ryan S, et al. Bilateral subdural collections--an unusual feature of possible Kawasaki disease. Eur J Paediatr Neurol 2001;5:79–81. 10.1053/ejpn.2001.0469 [DOI] [PubMed] [Google Scholar]
- 18. Constantinescu CS, Migraine CCS. Migraine and Raynaud phenomenon: possible late complications of Kawasaki disease. Headache 2002;42:227–9. 10.1046/j.1526-4610.2002.02057.x [DOI] [PubMed] [Google Scholar]
- 19. King WJ, Schlieper A, Birdi N, et al. The effect of Kawasaki disease on cognition and behavior. Arch Pediatr Adolesc Med 2000;154:463–8. 10.1001/archpedi.154.5.463 [DOI] [PubMed] [Google Scholar]
- 20. Nishad P, Singh S, Sidhu M, et al. Cognitive and behaviour assessment following Kawasaki disease--a study from North India. Rheumatol Int 2010;30:851–4. 10.1007/s00296-009-1078-1 [DOI] [PubMed] [Google Scholar]
- 21. Wang L-J, Kuo H-C. Cognitive development after Kawasaki disease - clinical study and validation using a nationwide population-based cohort. Circ J 2018;82:517–23. 10.1253/circj.CJ-17-0557 [DOI] [PubMed] [Google Scholar]
- 22. Dietz SM, van Stijn D, Burgner D, et al. Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr 2017;176:995–1009. 10.1007/s00431-017-2937-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Kourtidou S, Slee AE, Bruce ME, et al. Kawasaki disease substantially impacts health-related quality of life. J Pediatr 2018;193:155–63. 10.1016/j.jpeds.2017.09.070 [DOI] [PubMed] [Google Scholar]
- 24. Miura M, Kobayashi T, Kaneko T, et al. Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events. JAMA Pediatr 2018;172:e180030. 10.1001/jamapediatrics.2018.0030 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Chahal N, Clarizia NA, McCrindle BW, et al. Parental anxiety associated with Kawasaki disease in previously healthy children. J Pediatr Health Care 2010;24:250–7. 10.1016/j.pedhc.2009.07.002 [DOI] [PubMed] [Google Scholar]
- 26. Chahal N, Jelen A, Rush J, et al. Kawasaki disease with coronary artery aneurysms: psychosocial impact on parents and children. J Pediatr Health Care 2017;31:459–69. 10.1016/j.pedhc.2016.11.007 [DOI] [PubMed] [Google Scholar]
- 27. Jewell NP. Statistics for epidemiology. Boca Raton: CRC Press, 2003. [Google Scholar]
- 28. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on rheumatic fever, endocarditis, and Kawasaki disease, Council on cardiovascular disease in the young, American heart association. Pediatrics 2004;114:1708–33. 10.1542/peds.2004-2182 [DOI] [PubMed] [Google Scholar]
- 29. Kuo H-C, Hsieh K-S, Ming-Huey Guo M, et al. Next-Generation sequencing identifies micro-RNA-based biomarker panel for Kawasaki disease. J Allergy Clin Immunol 2016;138:1227–30. 10.1016/j.jaci.2016.04.050 [DOI] [PubMed] [Google Scholar]
- 30. Kuo H-C, Wang C-L, Liang C-D, et al. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease. Pediatr Allergy Immunol 2009;20:266–72. 10.1111/j.1399-3038.2008.00779.x [DOI] [PubMed] [Google Scholar]
- 31. Kuo H-C, Yang KD, Liang C-D, et al. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol 2007;18:354–9. 10.1111/j.1399-3038.2007.00516.x [DOI] [PubMed] [Google Scholar]
- 32. Kuo H-C, Chang J-C, Kuo H-C, et al. Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array. Arthritis Rheumatol 2015;67:828–36. 10.1002/art.38976 [DOI] [PubMed] [Google Scholar]
- 33. Mullen EM. Mullen scales of early learning item administration book. Circle Pines, MN: American Guidance Service, 1995. [Google Scholar]
- 34. Tsai J-M, Lu L, Jeng S-F, et al. Validation of the modified checklist for autism in toddlers, revised with follow-up in Taiwanese toddlers. Res Dev Disabil 2019;85:205–16. 10.1016/j.ridd.2018.11.011 [DOI] [PubMed] [Google Scholar]
- 35. Wechsler D. Wechsler preschool and primary scales of intelligence (4th ed) (WPPSI-IV). San Antonio, TX: Psychological Corporation, 2012. [Google Scholar]
- 36. Watkins MW, Beaujean AA. Bifactor structure of the Wechsler Preschool and Primary Scale of Intelligence--Fourth Edition. Sch Psychol Q 2014;29:52–63. 10.1037/spq0000038 [DOI] [PubMed] [Google Scholar]
- 37. Lee Y-C, Lin C-H, Tsai C-H, et al. Association between executing theory of mind in a limited experimental context and executing it in daily contexts in children with autism spectrum disorder: a cross-sectional study. Am J Occup Ther 2019;73:7303205150p1–11. 10.5014/ajot.2019.031773 [DOI] [PubMed] [Google Scholar]
- 38. Baron IS. Test review: Wechsler intelligence scale for Children-Fourth edition (WISC-IV). Child Neuropsychol 2005;11:471–5. 10.1080/09297040590951587 [DOI] [PubMed] [Google Scholar]
- 39. Yang P, Cheng C-P, Chang C-L, et al. Wechsler intelligence scale for children 4th edition-Chinese version index scores in Taiwanese children with attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci 2013;67:83–91. 10.1111/pcn.12014 [DOI] [PubMed] [Google Scholar]
- 40. Wang L-J, Chan W-C, Chou M-C, et al. Polymorphisms of STS gene and SULT2A1 gene and neurosteroid levels in Han Chinese boys with attention-deficit/hyperactivity disorder: an exploratory investigation. Sci Rep 2017;7:45595. 10.1038/srep45595 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Loyd BH, Abidin RR. Revision of the parenting stress index. J Pediatr Psychol 1985;10:169–77. 10.1093/jpepsy/10.2.169 [DOI] [PubMed] [Google Scholar]
- 42. Haskett ME, Ahern LS, Ward CS, et al. Factor structure and validity of the parenting stress index-short form. J Clin Child Adolesc Psychol 2006;35:302–12. 10.1207/s15374424jccp3502_14 [DOI] [PubMed] [Google Scholar]
- 43. Yeh CH, Chen ML, Li W, et al. The Chinese version of the parenting stress index: a psychometric study. Acta Paediatr 2001;90:1470–7. 10.1111/j.1651-2227.2001.tb01615.x [DOI] [PubMed] [Google Scholar]
- 44. Chen Y-C, Hwang-Gu S-L, Ni H-C, et al. Relationship between parenting stress and informant discrepancies on symptoms of ADHD/ODD and internalizing behaviors in preschool children. PLoS One 2017;12:e0183467. 10.1371/journal.pone.0183467 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Huang C-Y, Yen H-C, Tseng M-H, et al. Impacts of autistic behaviors, emotional and behavioral problems on parenting stress in caregivers of children with autism. J Autism Dev Disord 2014;44:1383–90. 10.1007/s10803-013-2000-y [DOI] [PubMed] [Google Scholar]
- 46. Garson G. Testing statistical assumptions. USA: Statistical Associates Publishing, 2012. [Google Scholar]
- 47. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association. Circulation 2017;135:e927–99. 10.1161/CIR.0000000000000484 [DOI] [PubMed] [Google Scholar]
- 48. Cavallo F, Chiarelli F. An outbreak of Kawasaki-like disease in children during SARS-CoV- 2 epidemic: no surprise? Acta Biomed 2020;91:e2020015. 10.23750/abm.v91i3.10305 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Berardicurti O, Conforti A, Ruscitti P, et al. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection. Expert Rev Clin Immunol 2020;16:1205–15. 10.1080/1744666X.2021.1847643 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data are available upon reasonable request.
